Table II.
Demographic and clinical characteristics of patients with Leishmania spp. DNA detected
| Characteristics | Number of patients with Leishmania; n (%) | |
|---|---|---|
| Gender | Male | 11 (48) |
| Female | 12 (52) | |
| Age (yr; range) | Male | 69 (26-88) |
| Median (range) | Female | 47 (18-90) |
| Region | Central Anatolia region | 21 (91.3) |
| Black sea region | 2 (8.7) | |
| Clinical lesions* | Head | 10 (43.5) |
| Body | 3 (13) | |
| Extremity | 10 (43.5) | |
| Diagnosis† | Squamous cell carcinoma | 4 (17.4) |
| Basal cell carcinoma | 1 (4.4) | |
| Psoriasis | 12 (52.1) | |
| Actinic keratoses | 4 (17.4) | |
| Seborrheic keratoses | 2 (8.7) | |
| Lesion (n) | Single | 7 (30.4) |
| Multiple | 3 (13) | |
| No data | 13(56.5) | |
| Type of lesion | Macule | 1 (4.3) |
| Papule or squamous papule | 2 (8.7) | |
| Plaque (squamous and/or erythematous) | 8 (34.8) | |
| Pustule | 1 (4.3) | |
| Ulcer | 1 (4.3) | |
| No data | 10 (43.5) | |
| Lesion duration | <1 yr | 5 (21.7) |
| ≥1 yr | 1 (4.4) | |
| No data | 17 (73.9) | |
| Treatment | Excision | 5 (21.7) |
| Topical calcipotriol and/or topical steroid | 10 (43.5) | |
| Cyclosporine | 1 (4.4) | |
| No data | 7 (30.4) | |
*Clinical lesions: Head (10): Forehead: 3, Face: 4, Scalp: 1, Infraorbital: 1, Unspecified: 1. Body (3): Back: 1, Unspecified: 2. Upper extremity (6): Palmoplantar: 1, Finger: 1, Hand: 1, Unspecified: 3. Lower extremity (2): Unspecified: 2. Upper and lower extremity (2): Unspecified:2. No travel history data. †Pathological